Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis

Retention of lipoproteins to proteoglycans in the subendothelial matrix (SEM) is an early event in atherosclerosis. We recently reported that collagen XVIII and its proteolytically released fragment endostatin (ES) are differentially depleted in blood vessels affected by atherosclerosis. Loss of col...

Full description

Bibliographic Details
Main Authors: Xiaokun Zeng, Joshua Chen, Yury I. Miller, Kashi Javaherian, Karen S. Moulton
Format: Article
Language:English
Published: Elsevier 2005-09-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S002222752032931X
_version_ 1818640075006672896
author Xiaokun Zeng
Joshua Chen
Yury I. Miller
Kashi Javaherian
Karen S. Moulton
author_facet Xiaokun Zeng
Joshua Chen
Yury I. Miller
Kashi Javaherian
Karen S. Moulton
author_sort Xiaokun Zeng
collection DOAJ
description Retention of lipoproteins to proteoglycans in the subendothelial matrix (SEM) is an early event in atherosclerosis. We recently reported that collagen XVIII and its proteolytically released fragment endostatin (ES) are differentially depleted in blood vessels affected by atherosclerosis. Loss of collagen XVIII/ES in atherosclerosis-prone mice enhanced plaque neovascularization and increased the vascular permeability to lipids by distinct mechanisms. Impaired endothelial barrier function increased the influx of lipoproteins across the endothelium; however, we hypothesized that enhanced retention might be a second mechanism leading to the increased lipid content in atheromas lacking collagen XVIII. We now demonstrate a novel property of ES that binds both the matrix proteoglycan biglycan and LDL and interferes with LDL retention to biglycan and to SEM. A peptide encompassing the α coil in the ES crystal structure mediates the major blocking effect of ES on LDL retention. ES inhibits the macrophage uptake of biglycan-associated LDL indirectly by interfering with LDL retention to biglycan, but it has no direct effect on the macrophage uptake of native or modified lipoproteins.Thus, loss of ES in advanced atheromas enhances lipoprotein retention in SEM. Our data reveal a third protective role of this vascular basement membrane component during atherosclerosis.
first_indexed 2024-12-16T23:05:30Z
format Article
id doaj.art-d80d50c2ebbd4aafa96e628fb0bca127
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-16T23:05:30Z
publishDate 2005-09-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-d80d50c2ebbd4aafa96e628fb0bca1272022-12-21T22:12:35ZengElsevierJournal of Lipid Research0022-22752005-09-0146918491859Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosisXiaokun Zeng0Joshua Chen1Yury I. Miller2Kashi Javaherian3Karen S. Moulton4Vascular Biology Program, Department of Surgery, Children's Hospital, Boston, MA 02115Vascular Biology Program, Department of Surgery, Children's Hospital, Boston, MA 02115Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, La Jolla, CA 92093Vascular Biology Program, Department of Surgery, Children's Hospital, Boston, MA 02115To whom correspondence should be addressed.; Vascular Biology Program, Department of Surgery, Children's Hospital, Boston, MA 02115; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115Retention of lipoproteins to proteoglycans in the subendothelial matrix (SEM) is an early event in atherosclerosis. We recently reported that collagen XVIII and its proteolytically released fragment endostatin (ES) are differentially depleted in blood vessels affected by atherosclerosis. Loss of collagen XVIII/ES in atherosclerosis-prone mice enhanced plaque neovascularization and increased the vascular permeability to lipids by distinct mechanisms. Impaired endothelial barrier function increased the influx of lipoproteins across the endothelium; however, we hypothesized that enhanced retention might be a second mechanism leading to the increased lipid content in atheromas lacking collagen XVIII. We now demonstrate a novel property of ES that binds both the matrix proteoglycan biglycan and LDL and interferes with LDL retention to biglycan and to SEM. A peptide encompassing the α coil in the ES crystal structure mediates the major blocking effect of ES on LDL retention. ES inhibits the macrophage uptake of biglycan-associated LDL indirectly by interfering with LDL retention to biglycan, but it has no direct effect on the macrophage uptake of native or modified lipoproteins.Thus, loss of ES in advanced atheromas enhances lipoprotein retention in SEM. Our data reveal a third protective role of this vascular basement membrane component during atherosclerosis.http://www.sciencedirect.com/science/article/pii/S002222752032931Xlow density lipoproteinextracellular matrixvascular basement membraneproteoglycanscollagen XVIII
spellingShingle Xiaokun Zeng
Joshua Chen
Yury I. Miller
Kashi Javaherian
Karen S. Moulton
Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis
Journal of Lipid Research
low density lipoprotein
extracellular matrix
vascular basement membrane
proteoglycans
collagen XVIII
title Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis
title_full Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis
title_fullStr Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis
title_full_unstemmed Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis
title_short Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis
title_sort endostatin binds biglycan and ldl and interferes with ldl retention to the subendothelial matrix during atherosclerosis
topic low density lipoprotein
extracellular matrix
vascular basement membrane
proteoglycans
collagen XVIII
url http://www.sciencedirect.com/science/article/pii/S002222752032931X
work_keys_str_mv AT xiaokunzeng endostatinbindsbiglycanandldlandinterfereswithldlretentiontothesubendothelialmatrixduringatherosclerosis
AT joshuachen endostatinbindsbiglycanandldlandinterfereswithldlretentiontothesubendothelialmatrixduringatherosclerosis
AT yuryimiller endostatinbindsbiglycanandldlandinterfereswithldlretentiontothesubendothelialmatrixduringatherosclerosis
AT kashijavaherian endostatinbindsbiglycanandldlandinterfereswithldlretentiontothesubendothelialmatrixduringatherosclerosis
AT karensmoulton endostatinbindsbiglycanandldlandinterfereswithldlretentiontothesubendothelialmatrixduringatherosclerosis